Sand, M., Nakagome, K., Cordes, J., Brenner, R., Gründer, G., Keefe, R., … Brown, D. (2018). T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. In Biological Psychiatry (Vol. 83, pp. S207–S208). Elsevier BV. https://doi.org/10.1016/j.biopsych.2018.02.542

Sand, Michael, Kazuyuki Nakagome, Joachim Cordes, Ronald Brenner, Gerhard Gründer, Richard Keefe, Robert Riesenberg, et al. “T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.” In Biological Psychiatry, 83:S207–8. Elsevier BV, 2018. https://doi.org/10.1016/j.biopsych.2018.02.542.

Sand M, Nakagome K, Cordes J, Brenner R, Gründer G, Keefe R, et al. T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. In: Biological Psychiatry. Elsevier BV; 2018. p. S207–8.

Sand, Michael, et al. “T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.” Biological Psychiatry, vol. 83, no. 9, Elsevier BV, 2018, pp. S207–08. Crossref, doi:10.1016/j.biopsych.2018.02.542.

Sand M, Nakagome K, Cordes J, Brenner R, Gründer G, Keefe R, Riesenberg R, Walling D, Daniels K, Wang L, Carter K, Brown D. T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Biological Psychiatry. Elsevier BV; 2018. p. S207–S208.